EUVIMEDOpdag EUVIMED
Open access

Constitutive mTORC1 activation in skeletal muscle increases inflammation but is not sufficient to impair glucose tolerance

Erik D Marchant, Hanna Kalenta, Sean P Kilroe, Jacquelyn May, Wenjun Z Martini, Korri S Weldon, Zhao Lai, Blake B Rasmussen iD

Function · 2026-08-01 · 7 (4)

DOI: 10.1152/function.039.2026 ↗

At a glance

Journal article in Function, published on 2026-08-01. Written by Erik D Marchant and 7 co-authors. Institution: Department of Cellular and Integrative Physiology, Long School of Medicine, University of Texas at San Antonio, San Antonio, Texas, United States. Major MEDLINE topics: Mechanistic Target of Rapamycin Complex 1, Muscle, Skeletal, Inflammation, Glucose Intolerance. Cited 1 times so far (Crossref); 43 references. The full text is freely available in PubMed Central. Funded by: NCI NIH HHS, NIH HHS, NIA NIH HHS.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Chronic skeletal muscle mTORC1 hyperactivation is widely assumed to drive insulin resistance and metabolic decline, yet direct causal evidence remains limited. Using adult-onset Depdc5 deletion to constitutively activate mTORC1 via GATOR1 disruption, we show that this is insufficient to impair glucose homeostasis even under a Western diet challenge. Strikingly, glucose tolerance and mitochondrial respiration remained preserved despite inflammation and immune transcriptional reprogramming—challenging the prevailing model of mTORC1-driven metabolic dysfunction in muscle.

Subjects

MeSH terms (MEDLINE)

Mechanistic Target of Rapamycin Complex 1Muscle, SkeletalInflammationGlucose IntoleranceAnimalsFemaleMiceInsulin ResistanceMice, KnockoutMaleSignal TransductionOxidative StressGlucose

Author keywords

insulin resistancemTORC1mitochondrial functionskeletal muscle

Substances

Mechanistic Target of Rapamycin Complex 1Glucose

Authors and institutions

  • Department of Cellular and Integrative Physiology, Long School of Medicine, University of Texas at San Antonio, San Antonio, Texas, United States.
  • Barshop Institute for Longevity and Aging Studies, University of Texas at San Antonio, San Antonio, Texas, United States.
  • Greehey Children's Cancer Research Institute, University of Texas at San Antonio, San Antonio, Texas, United States.
  • Department of Molecular Medicine, Long School of Medicine, University of Texas at San Antonio, San Antonio, Texas, United States.

ORCID profiles: Blake B Rasmussen

Funding

  • NCI NIH HHS
  • NIH HHS
  • NIA NIH HHS
  • CPRIT
  • NIH/NCI
  • NIH
  • NIH/NIA

Cite

APA

Marchant, E. D., Kalenta, H., Kilroe, S. P., May, J., Martini, W. Z., Weldon, K. S., Lai, Z., & Rasmussen, B. B. (2026). Constitutive mTORC1 activation in skeletal muscle increases inflammation but is not sufficient to impair glucose tolerance. Function, 7(4). https://doi.org/10.1152/function.039.2026

Vancouver

Marchant ED, Kalenta H, Kilroe SP, May J, Martini WZ, Weldon KS, et al. Constitutive mTORC1 activation in skeletal muscle increases inflammation but is not sufficient to impair glucose tolerance. Function. 2026;7(4). doi:10.1152/function.039.2026

BibTeX
@article{Marchant2026,
  author = {Marchant, Erik D and Kalenta, Hanna and Kilroe, Sean P and May, Jacquelyn and Martini, Wenjun Z and Weldon, Korri S and Lai, Zhao and Rasmussen, Blake B},
  title = {Constitutive mTORC1 activation in skeletal muscle increases inflammation but is not sufficient to impair glucose tolerance},
  journal = {Function},
  year = {2026},
  volume = {7},
  number = {4},
  doi = {10.1152/function.039.2026}
}
Start for free →